Provectus Biopharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Provectus Biopharmaceuticals's balance sheet done over the years? Its assets were worth $1,448,843 last year, which is less than in the previous period. 624% of Provectus Biopharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $9,042,194, which means an increase by 9% compared compared to last year.
Debt to Assets
| 2014 | 26184158 | 994.28K | 3.8% |
|---|---|---|---|
| 2015 | 20439812 | 4.12M | 20.17% |
| 2016 | 5611010 | 2.14M | 38.17% |
| 2017 | 3436397 | 13.45M | 391.55% |
| 2018 | 1988224 | 19.40M | 976.03% |
| 2019 | 1476904 | 25.54M | 1729.9% |
| 2020 | 589201 | 30.79M | 5226.66% |
| 2021 | 3513356 | 7.70M | 219.18% |
| 2022 | 2037246 | 8.26M | 405.73% |
| 2023 | 1448843 | 9.04M | 624.1% |
PVCT Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 76.57K | 21.60K | 682.98K | 97.23K | 590.70K | 50.98K | 105.50K | 1.16M | 14.17M | 17.39M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 476 | 394 | 5.10K | 3.93K | 55.05K | 595.32K | 452.37K | 300K | 500K | 733.33K |
Inventory | 0 | 1.41M | 2.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 1.28M | 467.08K | 329.90K | 322.51K | 350.24K | 370.20K | 400.41K | 360.56K | 41.19K | 978K |
Total current assets | 1.36M | 1.89M | 3.44M | 423.67K | 996.01K | 1.01M | 958.29K | 1.82M | 14.72M | 19.10M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 84.04K | 138.06K | 71.39K | 165.52K | 252.78K | 72.47K | 86.56K | 72.03K | 85.14K | 92.17K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 228.10K | 899.22K | 1.57M | 2.24M | 2.91M | 3.58M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 821.18K | 1.47M | 2.69M | 0 |
Other non-current assets | 0 | -138.06K | -71.39K | -165.52K | -480.89K | 0 | 821.18K | 0 | 2.72M | 3.40M |
Total non-current assets | 84.04K | 138.06K | 71.39K | 165.52K | 480.89K | 971.70K | 2.47M | 3.78M | 5.71M | 7.08M |
Total assets | 1.44M | 2.03M | 3.51M | 589.20K | 1.47M | 1.98M | 3.43M | 5.61M | 20.43M | 26.18M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 953.24K | 1.51M | 2.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short term debt | 3.04M | 2.11M | 1.74M | 23.71M | 576.42K | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 9.01M | 8.19M | 7.70M | 30.71M | 3.02M | 4.10M | 3.99M | 2.14M | 4.12M | 847.72K |
| Non-current liabilities: | ||||||||||
Long term debt | 25.29K | 73.37K | 0 | 83.84K | 19.79M | 13.93M | 9.45M | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 0 | 2.72M | 1.37M | 0 | 1.91M | 0 | 146.56K |
Total non-current liabilities | 25.29K | 73.37K | 0 | 83.84K | 22.52M | 15.30M | 9.45M | 1.91M | 1.88M | 146.56K |
Total liabilities | 9.04M | 8.26M | 7.70M | 30.79M | 25.54M | 19.40M | 13.45M | 2.14M | 4.12M | 994.28K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |